🔗 Share this article

A shadow market for unapproved slimming medications is propelled by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these accounts directly for supplier links, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a robust trade exists on Telegram, where groups with numerous of members share comparison photos, injection guides and claims of rapid UK delivery. Sellers market the substance there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and chemists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.

Several professionals stated the popularity for retatrutide could be connected to the rising price of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.

Several content creators try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and customer regulations, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Content Removal

Based on TikTok, the platform has taken down problematic content and banned related keywords and query recommendations. The company stated it was committed to keeping the platform secure and investing in strengthening compliance measures.

Digital Marketplace Activities

Research also found communities with up to nine thousand members marketing retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, populated with images of slimming results, glowing reviews and detailed instructions for preparing or injecting at home.

After moments of entering one community, a vendor shared WhatsApp details, where the majority of transactions occur. The vendor sent an instruction manual and guaranteed shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.

Product Information and Pricing

Inside these communities, posts show dark colored packages with postal service labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for the messaging service stated it actively moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting materials they can’t verify. Even if the science behind this drug is sound, these online versions may not include what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake injections are extremely risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has previously seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to possibly serious health risks”.